Search results
Results from the WOW.Com Content Network
Here's how the vaccine works, when it might become available, and who it might benefit. A Lyme disease vaccine has entered phase 3 clinical trials, per Pfizer. Here's how the vaccine works, when ...
Pfizer, the maker of a COVID-19 vaccine, announced Monday it is starting a phase 3 clinical trial on its Lyme disease vaccine, known as VLA15. The study will include over 6,000 participants from ...
VLA15, a vaccine against Lyme disease that is planned for release around 2024. A vaccine against Clostridiodes difficile infection; A vaccine against the Zika virus; On 20 June 2022, American biotech firm Pfizer announced a 90.5 million euro ($95.24 million) investment, buying an 8.1% stake in Valneva as part of a partnership to tackle Lyme ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
Sep. 21—Researchers developing a Lyme disease vaccine are seeking local residents to participate in a clinical trial. "There's so much more to be discovered," Dr. Jackson Booth said of how ...
If phase 3 pans out, they may have the first Lyme vaccine in 20 years. 20 years ago, a Lyme-disease vaccine was taken off the market. Now, 2 companies are developing one that could be available by ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us